APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceftazidime

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ceftazidime Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchCeftazidime Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceftazidime Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Ceftazidime Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceftazidime Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceftazidime Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ceftazidime market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ceftazidime is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ceftazidime is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ceftazidime is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ceftazidime include Fujian Fukang Pharmaceutical, NCPC, United Laboratories, Sinopharm Sandwich, Shanghai Pharmaceutical, Union Chempharma and Youcare Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ceftazidime market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ceftazidime market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ceftazidime market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ceftazidime.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ceftazidime market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ceftazidime Market by Company

Fujian Fukang Pharmaceutical

NCPC

United Laboratories

Sinopharm Sandwich

Shanghai Pharmaceutical

Union Chempharma

Youcare Pharmaceutical

Ceftazidime Segment by Type

Powder Injection

Injection

Ceftazidime Segment by Application

Respiratory Infections

Urinary Infections

Skin Infections

Other

Ceftazidime Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftazidime market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceftazidime and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftazidime.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ceftazidime manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ceftazidime in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Powder Injection Table 2. Major Company of Injection Table 3. Global Ceftazidime Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ceftazidime Sales by Type (2021-2026) & (tons) Table 5. Global Ceftazidime Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ceftazidime Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ceftazidime Sales Market Share in Value by Type (2021-2026) Table 8. Global Ceftazidime Price by Type (2021-2026) & (US$/kg) Table 9. Global Ceftazidime Sales by Type (2027-2032) & (tons) Table 10. Global Ceftazidime Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ceftazidime Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ceftazidime Sales Market Share in Value by Type (2027-2032) Table 13. Global Ceftazidime Price by Type (2027-2032) & (US$/kg) Table 14. North America Ceftazidime Sales by Type (2021-2026) & (tons) Table 15. North America Ceftazidime Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ceftazidime Sales by Type (2021-2026) & (tons) Table 17. Europe Ceftazidime Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ceftazidime Sales by Type (2021-2026) & (tons) Table 19. Asia-Pacific Ceftazidime Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ceftazidime Sales by Type (2021-2026) & (tons) Table 21. Latin America Ceftazidime Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ceftazidime Sales by Type (2021-2026) & (tons) Table 23. Middle East and Africa Ceftazidime Sales by Type (2021-2026) & (US$ Million) Table 24. Ceftazidime Industry Trends Table 25. Ceftazidime Industry Drivers Table 26. Ceftazidime Industry Opportunities and Challenges Table 27. Ceftazidime Industry Restraints Table 28. Global Ceftazidime Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ceftazidime Revenue Market Share by Company (2021-2026) Table 30. Global Ceftazidime Sales by Company (2021-2026) & (tons) Table 31. Global Ceftazidime Sales Share by Company (2021-2026) Table 32. Global Ceftazidime Market Price by Company (2021-2026) & (US$/kg) Table 33. Global Ceftazidime Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ceftazidime Major Company Production Sites and Headquarters Table 35. Global Ceftazidime Company, Product Type & Application Table 36. Global Ceftazidime Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ceftazidime by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ceftazidime Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ceftazidime Sales by Region (2021-2026) & (tons) Table 41. Global Ceftazidime Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ceftazidime Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ceftazidime Sales Market Share in Value by Region (2021-2026) Table 44. Global Ceftazidime Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 45. Global Ceftazidime Sales by Region (2027-2032) & (tons) Table 46. Global Ceftazidime Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ceftazidime Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ceftazidime Sales Market Share in Value by Region (2027-2032) Table 49. Global Ceftazidime Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 50. Global Ceftazidime Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ceftazidime Sales by Application (2021-2026) & (tons) Table 52. Global Ceftazidime Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ceftazidime Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ceftazidime Sales Market Share in Value by Application (2021-2026) Table 55. Global Ceftazidime Price by Application (2021-2026) & (US$/kg) Table 56. Global Ceftazidime Sales by Application (2027-2032) & (tons) Table 57. Global Ceftazidime Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ceftazidime Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ceftazidime Sales Market Share in Value by Application (2027-2032) Table 60. Global Ceftazidime Price by Application (2027-2032) & (US$/kg) Table 61. North America Ceftazidime Sales by Application (2021-2026) & (tons) Table 62. North America Ceftazidime Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ceftazidime Sales by Application (2021-2026) & (tons) Table 64. Europe Ceftazidime Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ceftazidime Sales by Application (2021-2026) & (tons) Table 66. Asia-Pacific Ceftazidime Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ceftazidime Sales by Application (2021-2026) & (tons) Table 68. Latin America Ceftazidime Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ceftazidime Sales by Application (2021-2026) & (tons) Table 70. Middle East and Africa Ceftazidime Sales by Application (2021-2026) & (US$ Million) Table 71. Fujian Fukang Pharmaceutical Company Information Table 72. Fujian Fukang Pharmaceutical Business Overview Table 73. Fujian Fukang Pharmaceutical Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Fujian Fukang Pharmaceutical Ceftazidime Product Portfolio Table 75. Fujian Fukang Pharmaceutical Recent Development Table 76. NCPC Company Information Table 77. NCPC Business Overview Table 78. NCPC Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. NCPC Ceftazidime Product Portfolio Table 80. NCPC Recent Development Table 81. United Laboratories Company Information Table 82. United Laboratories Business Overview Table 83. United Laboratories Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. United Laboratories Ceftazidime Product Portfolio Table 85. United Laboratories Recent Development Table 86. Sinopharm Sandwich Company Information Table 87. Sinopharm Sandwich Business Overview Table 88. Sinopharm Sandwich Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Sinopharm Sandwich Ceftazidime Product Portfolio Table 90. Sinopharm Sandwich Recent Development Table 91. Shanghai Pharmaceutical Company Information Table 92. Shanghai Pharmaceutical Business Overview Table 93. Shanghai Pharmaceutical Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Shanghai Pharmaceutical Ceftazidime Product Portfolio Table 95. Shanghai Pharmaceutical Recent Development Table 96. Union Chempharma Company Information Table 97. Union Chempharma Business Overview Table 98. Union Chempharma Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Union Chempharma Ceftazidime Product Portfolio Table 100. Union Chempharma Recent Development Table 101. Youcare Pharmaceutical Company Information Table 102. Youcare Pharmaceutical Business Overview Table 103. Youcare Pharmaceutical Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Youcare Pharmaceutical Ceftazidime Product Portfolio Table 105. Youcare Pharmaceutical Recent Development Table 106. North America Ceftazidime Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 107. North America Ceftazidime Sales by Country (2021-2026) & (tons) Table 108. North America Ceftazidime Sales Market Share by Country (2021-2026) Table 109. North America Ceftazidime Sales Forecast by Country (2027-2032) & (tons) Table 110. North America Ceftazidime Sales Market Share Forecast by Country (2027-2032) Table 111. North America Ceftazidime Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Ceftazidime Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Ceftazidime Market Share by Country (2021-2026) Table 114. North America Ceftazidime Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Ceftazidime Market Share Forecast by Country (2027-2032) Table 116. Europe Ceftazidime Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 117. Europe Ceftazidime Sales by Country (2021-2026) & (tons) Table 118. Europe Ceftazidime Sales Market Share by Country (2021-2026) Table 119. Europe Ceftazidime Sales Forecast by Country (2027-2032) & (tons) Table 120. Europe Ceftazidime Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Ceftazidime Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Ceftazidime Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Ceftazidime Market Share by Country (2021-2026) Table 124. Europe Ceftazidime Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Ceftazidime Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Ceftazidime Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Ceftazidime Sales by Country (2021-2026) & (tons) Table 128. Asia-Pacific Ceftazidime Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Ceftazidime Sales Forecast by Country (2027-2032) & (tons) Table 130. Asia-Pacific Ceftazidime Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Ceftazidime Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Ceftazidime Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Ceftazidime Market Share by Country (2021-2026) Table 134. Asia-Pacific Ceftazidime Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Ceftazidime Market Share Forecast by Country (2027-2032) Table 136. Latin America Ceftazidime Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 137. Latin America Ceftazidime Sales by Country (2021-2026) & (tons) Table 138. Latin America Ceftazidime Sales Market Share by Country (2021-2026) Table 139. Latin America Ceftazidime Sales Forecast by Country (2027-2032) & (tons) Table 140. Latin America Ceftazidime Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Ceftazidime Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Ceftazidime Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Ceftazidime Market Share by Country (2021-2026) Table 144. Latin America Ceftazidime Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Ceftazidime Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Ceftazidime Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Ceftazidime Sales by Country (2021-2026) & (tons) Table 148. Middle East and Africa Ceftazidime Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Ceftazidime Sales Forecast by Country (2027-2032) & (tons) Table 150. Middle East and Africa Ceftazidime Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Ceftazidime Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Ceftazidime Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Ceftazidime Market Share by Country (2021-2026) Table 154. Middle East and Africa Ceftazidime Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Ceftazidime Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Ceftazidime Distributors List Table 159. Ceftazidime Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Ceftazidime Image Figure 2. Global Ceftazidime Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceftazidime Market Size (2021-2032) & (US$ Million) Figure 4. Global Ceftazidime Sales (2021-2032) & (tons) Figure 5. Powder Injection Image Figure 6. Global Powder Injection Sales YoY Growth (2021-2032) & (tons) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (tons) Figure 9. Global Ceftazidime Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ceftazidime Market Share by Type 2025 VS 2032 Figure 11. North America Ceftazidime Sales Market Share in Volume by Type in 2025 Figure 12. North America Ceftazidime Sales Market Share in Value by Type in 2025 Figure 13. Europe Ceftazidime Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ceftazidime Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ceftazidime Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ceftazidime Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ceftazidime Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ceftazidime Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ceftazidime Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ceftazidime Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ceftazidime Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Respiratory Infections Image Figure 24. Global Respiratory Infections Sales YoY Growth (2021-2032) & (tons) Figure 25. Urinary Infections Image Figure 26. Global Urinary Infections Sales YoY Growth (2021-2032) & (tons) Figure 27. Skin Infections Image Figure 28. Global Skin Infections Sales YoY Growth (2021-2032) & (tons) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (tons) Figure 31. Global Ceftazidime Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Ceftazidime Market Share by Application 2025 VS 2032 Figure 33. North America Ceftazidime Sales Market Share in Volume by Application in 2025 Figure 34. North America Ceftazidime Sales Market Share in Value by Application in 2025 Figure 35. Europe Ceftazidime Sales Market Share in Volume by Application in 2025 Figure 36. Europe Ceftazidime Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Ceftazidime Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Ceftazidime Sales Market Share in Value by Application in 2025 Figure 39. Latin America Ceftazidime Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Ceftazidime Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Ceftazidime Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Ceftazidime Sales Market Share in Value by Application in 2025 Figure 43. North America Ceftazidime Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 44. North America Ceftazidime Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Ceftazidime Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ceftazidime Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 48. Europe Ceftazidime Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Ceftazidime Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ceftazidime Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 52. Asia-Pacific Ceftazidime Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Ceftazidime Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ceftazidime Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 56. Latin America Ceftazidime Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Ceftazidime Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ceftazidime Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 60. Middle East and Africa Ceftazidime Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Ceftazidime Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Ceftazidime Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Ceftazidime Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Ceftazidime Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Powder Injection
  • Injection
Applications
  • Respiratory Infections
  • Urinary Infections
  • Skin Infections
  • Other
Companies covered
  • Fujian Fukang Pharmaceutical
  • NCPC
  • United Laboratories
  • Sinopharm Sandwich
  • Shanghai Pharmaceutical
  • Union Chempharma
  • Youcare Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ceftazidime Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ceftazidime Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ceftazidime Market by Type
  6. 1.3.1 Powder Injection
  7. 1.3.2 Injection
  8. 1.4 Global Ceftazidime Market Size by Type
  9. 1.4.1 Global Ceftazidime Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ceftazidime Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ceftazidime Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ceftazidime Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ceftazidime Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ceftazidime Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ceftazidime Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ceftazidime Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ceftazidime Industry Trends
  2. 2.2 Ceftazidime Industry Drivers
  3. 2.3 Ceftazidime Industry Opportunities and Challenges
  4. 2.4 Ceftazidime Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ceftazidime Revenue (2021-2026)
  2. 3.2 Global Top Players by Ceftazidime Sales (2021-2026)
  3. 3.3 Global Top Players by Ceftazidime Price (2021-2026)
  4. 3.4 Global Ceftazidime Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ceftazidime Major Company Production Sites & Headquarters
  6. 3.6 Global Ceftazidime Company, Product Type & Application
  7. 3.7 Global Ceftazidime Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ceftazidime Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ceftazidime Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ceftazidime Tier 1, Tier 2, and Tier 3
4 Ceftazidime Regional Status and Outlook
  1. 4.1 Global Ceftazidime Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ceftazidime Historic Market Size by Region
  3. 4.2.1 Global Ceftazidime Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ceftazidime Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ceftazidime Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ceftazidime Forecasted Market Size by Region
  7. 4.3.1 Global Ceftazidime Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ceftazidime Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ceftazidime Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ceftazidime by Application
  1. 5.1 Ceftazidime Market by Application
  2. 5.1.1 Respiratory Infections
  3. 5.1.2 Urinary Infections
  4. 5.1.3 Skin Infections
  5. 5.1.4 Other
  6. 5.2 Global Ceftazidime Market Size by Application
  7. 5.2.1 Global Ceftazidime Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Ceftazidime Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Ceftazidime Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Ceftazidime Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Ceftazidime Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Ceftazidime Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Ceftazidime Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Ceftazidime Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Fujian Fukang Pharmaceutical
  2. 6.1.1 Fujian Fukang Pharmaceutical Company Information
  3. 6.1.2 Fujian Fukang Pharmaceutical Business Overview
  4. 6.1.3 Fujian Fukang Pharmaceutical Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Fujian Fukang Pharmaceutical Ceftazidime Product Portfolio
  6. 6.1.5 Fujian Fukang Pharmaceutical Recent Developments
  7. 6.2 NCPC
  8. 6.2.1 NCPC Company Information
  9. 6.2.2 NCPC Business Overview
  10. 6.2.3 NCPC Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 NCPC Ceftazidime Product Portfolio
  12. 6.2.5 NCPC Recent Developments
  13. 6.3 United Laboratories
  14. 6.3.1 United Laboratories Company Information
  15. 6.3.2 United Laboratories Business Overview
  16. 6.3.3 United Laboratories Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 United Laboratories Ceftazidime Product Portfolio
  18. 6.3.5 United Laboratories Recent Developments
  19. 6.4 Sinopharm Sandwich
  20. 6.4.1 Sinopharm Sandwich Company Information
  21. 6.4.2 Sinopharm Sandwich Business Overview
  22. 6.4.3 Sinopharm Sandwich Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sinopharm Sandwich Ceftazidime Product Portfolio
  24. 6.4.5 Sinopharm Sandwich Recent Developments
  25. 6.5 Shanghai Pharmaceutical
  26. 6.5.1 Shanghai Pharmaceutical Company Information
  27. 6.5.2 Shanghai Pharmaceutical Business Overview
  28. 6.5.3 Shanghai Pharmaceutical Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Pharmaceutical Ceftazidime Product Portfolio
  30. 6.5.5 Shanghai Pharmaceutical Recent Developments
  31. 6.6 Union Chempharma
  32. 6.6.1 Union Chempharma Company Information
  33. 6.6.2 Union Chempharma Business Overview
  34. 6.6.3 Union Chempharma Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Union Chempharma Ceftazidime Product Portfolio
  36. 6.6.5 Union Chempharma Recent Developments
  37. 6.7 Youcare Pharmaceutical
  38. 6.7.1 Youcare Pharmaceutical Company Information
  39. 6.7.2 Youcare Pharmaceutical Business Overview
  40. 6.7.3 Youcare Pharmaceutical Ceftazidime Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Youcare Pharmaceutical Ceftazidime Product Portfolio
  42. 6.7.5 Youcare Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Ceftazidime Sales by Country
  2. 7.1.1 North America Ceftazidime Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ceftazidime Sales by Country (2021-2026)
  4. 7.1.3 North America Ceftazidime Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ceftazidime Market Size by Country
  6. 7.2.1 North America Ceftazidime Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ceftazidime Market Size by Country (2021-2026)
  8. 7.2.3 North America Ceftazidime Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ceftazidime Sales by Country
  2. 8.1.1 Europe Ceftazidime Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ceftazidime Sales by Country (2021-2026)
  4. 8.1.3 Europe Ceftazidime Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ceftazidime Market Size by Country
  6. 8.2.1 Europe Ceftazidime Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ceftazidime Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ceftazidime Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ceftazidime Sales by Country
  2. 9.1.1 Asia-Pacific Ceftazidime Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ceftazidime Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ceftazidime Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ceftazidime Market Size by Country
  6. 9.2.1 Asia-Pacific Ceftazidime Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ceftazidime Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ceftazidime Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ceftazidime Sales by Country
  2. 10.1.1 South America Ceftazidime Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ceftazidime Sales by Country (2021-2026)
  4. 10.1.3 South America Ceftazidime Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ceftazidime Market Size by Country
  6. 10.2.1 South America Ceftazidime Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ceftazidime Market Size by Country (2021-2026)
  8. 10.2.3 South America Ceftazidime Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ceftazidime Sales by Country
  2. 11.1.1 Middle East and Africa Ceftazidime Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ceftazidime Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ceftazidime Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ceftazidime Market Size by Country
  6. 11.2.1 Middle East and Africa Ceftazidime Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ceftazidime Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ceftazidime Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ceftazidime Value Chain Analysis
  2. 12.1.1 Ceftazidime Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ceftazidime Production Mode & Process
  7. 12.2 Ceftazidime Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ceftazidime Distributors
  10. 12.2.3 Ceftazidime Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst